Submit Your Paper Instructions for Authors Instructions for Reviewers Editors in Chief Editorial Board Editorial Policies English Editing Service Indexing and Abstracting Archive

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info

Collaborator of

J Cardiovasc Thorac Res. 2017;9(4): 191-195. doi: 10.15171/jcvtr.2017.33

PMID: 29391931 PMCID: PMC5787330

Original Article

In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris

Rza Hajizadeh ¹, Samad Ghaffari ¹, Mojtaba Ziaee ² * , Behrooz Shokouhi ¹, Ahmad Separham ¹, Parvin Sarbakhsh ¹

Cited by CrossRef: 3

1- Leclerc J, Thibault M, Midiani Gonella J, Beaudoin C, Sampalis J. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis. Drugs. 2020;80(7):697 [Crossref]

2- Sicras-Mainar A, Escobar-Cervantes C, Micó-Pérez R, Llisterri-Caro J. Consecuencias clínicas y económicas en pacientes que inician tratamiento con clopidogrel de marca vs. genérico: estudio retrospectivo de vida real. Medicina de Familia SEMERGEN. 2020;46(1):16 [Crossref]

3- Chan C, Tung Y, Lee K, Chan Y, Chu P. Clinical outcomes of generic versus brand‐name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort study. Clinical Translational Sci. 2023;16(9):1594 [Crossref]

4- Zhang J, Sun Y, He J, Wu G, Wang R, Zhang J. Comprehensive Investigation of the Influence of High-Altitude Hypoxia on Clopidogrel Metabolism and Gut Microbiota. CDM. 2023;24(10):723 [Crossref]